BioStem Technologies, Inc. (BSEM)
NASDAQ: BSEM · Real-Time Price · USD
1.680
+0.040 (2.44%)
At close: Oct 21, 2026, 4:00 PM EDT
1.650
-0.030 (-1.79%)
After-hours: Oct 21, 2026, 7:30 PM EDT

BioStem Technologies Revenue

BioStem Technologies had revenue of $7.90M in the quarter ending June 30, 2026, a decrease of -27.95%. This brings the company's total for the last twelve months to $34.59M, down -49.13% year-over-year. In the year 2025, BioStem Technologies had annual revenue of $47.48M, down -31.84%. That makes BioStem Technologies the 30,453rd largest company in the world by revenue and 4,028th in the United States.

Revenue (ttm)
$34.59M
Revenue Growth
-49.13%
P/S Ratio
0.90
Revenue / Employee
$473,789
Employees
73
Market Cap
31.22M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202547.48M-22.18M-31.84%
Dec 31, 202469.66M52.97M317.48%
Dec 31, 202316.69M9.81M142.69%
Dec 31, 20226.88M2.53M58.38%
Dec 31, 20214.34M4.03M1,284.88%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Aligos Therapeutics31.52M
Metagenomi Therapeutics13.56M
Evaxion7.49M
EyePoint2.79M
CervoMed331.30K
Impact BioMedical35.00K
Revenue Rankings